ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 33 filers reported holding ENOCHIAN BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,957 | +689.4% | 1,780 | -0.1% | 0.00% | – |
| Q2 2023 | $1,008 | -96.2% | 1,781 | -93.9% | 0.00% | – |
| Q1 2023 | $26,529 | +8.9% | 28,993 | +22.6% | 0.00% | – |
| Q4 2022 | $24,364 | -51.3% | 23,654 | -14.5% | 0.00% | – |
| Q3 2022 | $50,000 | +614.3% | 27,667 | +730.1% | 0.00% | – |
| Q2 2022 | $7,000 | -95.6% | 3,333 | -82.6% | 0.00% | – |
| Q1 2022 | $158,000 | +43.6% | 19,202 | +27.4% | 0.00% | – |
| Q4 2021 | $110,000 | +746.2% | 15,074 | +457.9% | 0.00% | – |
| Q2 2021 | $13,000 | -88.2% | 2,702 | -91.3% | 0.00% | – |
| Q1 2021 | $110,000 | +423.8% | 31,115 | +325.5% | 0.00% | – |
| Q4 2020 | $21,000 | -12.5% | 7,312 | +7.0% | 0.00% | – |
| Q3 2020 | $24,000 | +33.3% | 6,836 | +58.1% | 0.00% | – |
| Q2 2020 | $18,000 | +63.6% | 4,324 | +20.3% | 0.00% | – |
| Q1 2020 | $11,000 | -42.1% | 3,595 | -2.9% | 0.00% | – |
| Q4 2019 | $19,000 | +216.7% | 3,704 | +226.9% | 0.00% | – |
| Q3 2019 | $6,000 | -88.0% | 1,133 | -89.9% | 0.00% | – |
| Q2 2019 | $50,000 | +2400.0% | 11,201 | +3284.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |